Pterostilbene is considered to be a corrosive substance, is dangerous upon exposure to the eyes, and is an environmental toxin, especially to aquatic life.[1]
A preliminary study of healthy human subjects given pterostilbene for 6–8 weeks, showed pterostilbene to be safe for human use at dosages up to 250 mg per day, although this study did not assess metabolic effects on the lipid profile.[8]
Its chemical relative, resveratrol, received FDA GRAS status in 2007,[10] and approval of synthetic resveratrol as a safe compound by the European Food Safety Authority (EFSA) in 2016.[11] Pterostilbene differs from resveratrol by exhibiting increased bioavailability (80% compared to 20% in resveratrol) due to the presence of two methoxy groups which cause it to exhibit increased lipophilic and oral absorption.[5]
Research
Pterostilbene is being studied in laboratory and preliminary clinical research.[1]
See also
Piceatannol, a stilbenoid related to both resveratrol and pterostilbene
References
^ abc"Pterostilbene, CID 5281727". PubChem, National Library of Medicine, US National Institutes of Health. 16 November 2019. Retrieved 18 November 2019.
^"GRAS Notice GRN 224: Resveratrol". US Food and Drug Administration, Food Ingredient and Packaging Inventories. 1 August 2007. Retrieved 7 February 2019.